CORLANOR Drug Profile, 2024: CORLANOR (ivabradine) drug patents, FDA exclusivity, litigation, drug prices

By DrugPatentWatch

CORLANOR Drug Profile, 2024

This report focuses on CORLANOR and covers the following critical aspects of this drug:

United States patentsDistrict Court patent litigationClinical trialsDrug pricesFinished product suppliersRaw active pharmaceutical ingredient (API) sourcesFREE UPDATE: Send your receipt to DrugPatentWatch within 30 days for a free updat

• Format: Paperback
• Language: English
• ISBN: B0CRZ17JFT
• ISBN13: 9798875586286
• Release Date: January 2024
• Publisher: Independently Published
• Length: 74 Pages
• Weight: 0.43 lbs.
• Dimensions: 0.1" x 8.5" x 11.0"